Cargando…
Suppressed Vascular Leakage and Myocardial Edema Improve Outcome From Myocardial Infarction
AIM: The acute phase of myocardial infarction (MI) is accompanied by edema contributing to tissue damage and disease outcome. Here, we aimed to identify the mechanism whereby vascular endothelial growth factor (VEGF)-A induces myocardial edema in the acute phase of MI to eventually promote developme...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363985/ https://www.ncbi.nlm.nih.gov/pubmed/32733273 http://dx.doi.org/10.3389/fphys.2020.00763 |
_version_ | 1783559752377171968 |
---|---|
author | Li, Xiujuan Redfors, Björn Sáinz-Jaspeado, Miguel Shi, Shujing Martinsson, Pernilla Padhan, Narendra Scharin Täng, Margareta Borén, Jan Levin, Malin Claesson-Welsh, Lena |
author_facet | Li, Xiujuan Redfors, Björn Sáinz-Jaspeado, Miguel Shi, Shujing Martinsson, Pernilla Padhan, Narendra Scharin Täng, Margareta Borén, Jan Levin, Malin Claesson-Welsh, Lena |
author_sort | Li, Xiujuan |
collection | PubMed |
description | AIM: The acute phase of myocardial infarction (MI) is accompanied by edema contributing to tissue damage and disease outcome. Here, we aimed to identify the mechanism whereby vascular endothelial growth factor (VEGF)-A induces myocardial edema in the acute phase of MI to eventually promote development of therapeutics to specifically suppress VEGFA-regulated vascular permeability while preserving collateral vessel formation. METHODS AND RESULTS: VEGFA regulates vascular permeability and edema by activation of VEGF receptor-2 (VEGFR2), leading to induction of several signaling pathways including the cytoplasmic tyrosine kinase c-Src. The activated c-Src in turn phosphorylates vascular endothelial (VE)-cadherin, leading to dissociation of endothelial adherens junctions. A particular tyrosine at position 949 in mouse VEGFR2 has been shown to be required for activation of c-Src. Wild-type mice and mice with phenylalanine replacing tyrosine (Y) 949 in VEGFR2 (Vegfr2(Y949F/Y949F)) were challenged with MI through permanent ligation of the left anterior descending coronary artery. The infarct size was similar in wild-type and mutant mice, but left ventricular wall edema and fibrinogen deposition, indicative of vascular leakage, were reduced in the Vegfr2(Y949F/Y949F) strain. When challenged with large infarcts, the Vegfr2(Y949F/Y949F) mice survived significantly better than the wild-type strain. Moreover, neutrophil infiltration and levels of myeloperoxidase were low in the infarcted Vegfr2(Y949F/Y949F) hearts, correlating with improved survival. In vivo tyrosine phosphorylation of VE-cadherin at Y685, implicated in regulation of vascular permeability, was induced by circulating VEGFA in the wild-type but remained at baseline levels in the Vegfr2(Y949F/Y949F) hearts. CONCLUSION: Suppression of VEGFA/VEGFR2-regulated vascular permeability leads to diminished edema without affecting vascular density correlating with improved myocardial parameters and survival after MI. |
format | Online Article Text |
id | pubmed-7363985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73639852020-07-29 Suppressed Vascular Leakage and Myocardial Edema Improve Outcome From Myocardial Infarction Li, Xiujuan Redfors, Björn Sáinz-Jaspeado, Miguel Shi, Shujing Martinsson, Pernilla Padhan, Narendra Scharin Täng, Margareta Borén, Jan Levin, Malin Claesson-Welsh, Lena Front Physiol Physiology AIM: The acute phase of myocardial infarction (MI) is accompanied by edema contributing to tissue damage and disease outcome. Here, we aimed to identify the mechanism whereby vascular endothelial growth factor (VEGF)-A induces myocardial edema in the acute phase of MI to eventually promote development of therapeutics to specifically suppress VEGFA-regulated vascular permeability while preserving collateral vessel formation. METHODS AND RESULTS: VEGFA regulates vascular permeability and edema by activation of VEGF receptor-2 (VEGFR2), leading to induction of several signaling pathways including the cytoplasmic tyrosine kinase c-Src. The activated c-Src in turn phosphorylates vascular endothelial (VE)-cadherin, leading to dissociation of endothelial adherens junctions. A particular tyrosine at position 949 in mouse VEGFR2 has been shown to be required for activation of c-Src. Wild-type mice and mice with phenylalanine replacing tyrosine (Y) 949 in VEGFR2 (Vegfr2(Y949F/Y949F)) were challenged with MI through permanent ligation of the left anterior descending coronary artery. The infarct size was similar in wild-type and mutant mice, but left ventricular wall edema and fibrinogen deposition, indicative of vascular leakage, were reduced in the Vegfr2(Y949F/Y949F) strain. When challenged with large infarcts, the Vegfr2(Y949F/Y949F) mice survived significantly better than the wild-type strain. Moreover, neutrophil infiltration and levels of myeloperoxidase were low in the infarcted Vegfr2(Y949F/Y949F) hearts, correlating with improved survival. In vivo tyrosine phosphorylation of VE-cadherin at Y685, implicated in regulation of vascular permeability, was induced by circulating VEGFA in the wild-type but remained at baseline levels in the Vegfr2(Y949F/Y949F) hearts. CONCLUSION: Suppression of VEGFA/VEGFR2-regulated vascular permeability leads to diminished edema without affecting vascular density correlating with improved myocardial parameters and survival after MI. Frontiers Media S.A. 2020-07-09 /pmc/articles/PMC7363985/ /pubmed/32733273 http://dx.doi.org/10.3389/fphys.2020.00763 Text en Copyright © 2020 Li, Redfors, Sáinz-Jaspeado, Shi, Martinsson, Padhan, Scharin Täng, Borén, Levin and Claesson-Welsh. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Li, Xiujuan Redfors, Björn Sáinz-Jaspeado, Miguel Shi, Shujing Martinsson, Pernilla Padhan, Narendra Scharin Täng, Margareta Borén, Jan Levin, Malin Claesson-Welsh, Lena Suppressed Vascular Leakage and Myocardial Edema Improve Outcome From Myocardial Infarction |
title | Suppressed Vascular Leakage and Myocardial Edema Improve Outcome From Myocardial Infarction |
title_full | Suppressed Vascular Leakage and Myocardial Edema Improve Outcome From Myocardial Infarction |
title_fullStr | Suppressed Vascular Leakage and Myocardial Edema Improve Outcome From Myocardial Infarction |
title_full_unstemmed | Suppressed Vascular Leakage and Myocardial Edema Improve Outcome From Myocardial Infarction |
title_short | Suppressed Vascular Leakage and Myocardial Edema Improve Outcome From Myocardial Infarction |
title_sort | suppressed vascular leakage and myocardial edema improve outcome from myocardial infarction |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363985/ https://www.ncbi.nlm.nih.gov/pubmed/32733273 http://dx.doi.org/10.3389/fphys.2020.00763 |
work_keys_str_mv | AT lixiujuan suppressedvascularleakageandmyocardialedemaimproveoutcomefrommyocardialinfarction AT redforsbjorn suppressedvascularleakageandmyocardialedemaimproveoutcomefrommyocardialinfarction AT sainzjaspeadomiguel suppressedvascularleakageandmyocardialedemaimproveoutcomefrommyocardialinfarction AT shishujing suppressedvascularleakageandmyocardialedemaimproveoutcomefrommyocardialinfarction AT martinssonpernilla suppressedvascularleakageandmyocardialedemaimproveoutcomefrommyocardialinfarction AT padhannarendra suppressedvascularleakageandmyocardialedemaimproveoutcomefrommyocardialinfarction AT scharintangmargareta suppressedvascularleakageandmyocardialedemaimproveoutcomefrommyocardialinfarction AT borenjan suppressedvascularleakageandmyocardialedemaimproveoutcomefrommyocardialinfarction AT levinmalin suppressedvascularleakageandmyocardialedemaimproveoutcomefrommyocardialinfarction AT claessonwelshlena suppressedvascularleakageandmyocardialedemaimproveoutcomefrommyocardialinfarction |